![Qiang Lü](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Qiang Lü
Directeur/Bestuurslid bij GOODY SCIENCE AND TECHNOLOGY CO., LTD.
Actieve functies van Qiang Lü
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Directeur/Bestuurslid | 28-12-2020 | - |
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Voorzitter | 22-08-2017 | - |
Oprichter | 22-08-2017 | - |
Loopbaan van Qiang Lü
Statistieken
Internationaal
China | 3 |
Operationeel
Director/Board Member | 1 |
Chairman | 1 |
Founder | 1 |
Sectoraal
Producer Manufacturing | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Producer Manufacturing |
Bedrijven in privébezit | 1 |
---|---|
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Commercial Services |